StockWatch
·

Virtuoso Optoelectronics Ltd Q2 FY27 Results

VOEPLQ2 FY27 Results
Filing
Result:Good· Market: Crashed#Turnaround#One-off gain#Margin expansion

Outlook: Cautiously Optimistic · Guidance: Maintained

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue177.0852.9%41.2%
Total Income178.1752.7%41.1%
Expenditure176.3151.5%40.3%
PBT1.8785.6%73.6%
Net Profit2.6970.3%5.7%
OPM11.18%2.05pp17.52pp
NPM1.51%0.89pp0.67pp
EPS0.7872.5%29.1%
View full financials

Consolidated revenue grew ~81% YoY and the quarter swung from a loss to profit with margins flat-to-better YoY, but a large share of the headline PAT came from a one-off tax-rate catch-up (adjusted consolidated PAT only ~₹1.4 Cr) and H1 NPM is tracking below the guided floor, so it's healthy but not a clean standout.

VIRTUOSO OPTOELECTRONICS LTD · QQ2 FY-2027 · THE CALL

H1 strength masks Q2 seasonal weakness; margins below guidance

The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.

09 Nov 2026 · 6 min read
Verdict

Hold

confidence 6/10

Credibility

Grade B

H1 delivery strong; Q2 miss on revenue and margins. Prior 35-40% FY27 growth now unclear if achievable; new 30%+ CAGR is multi-year, not specific.

Short-term outlook

Cautiously Optimistic

next 1–2 quarters

Long-term outlook

Optimistic

multi-year

H1 growth of 78% YoY (₹534 Cr) and strong order book underscore demand recovery. However, Q2 revenue collapsed 41% YoY (₹177 Cr) and NPM at 1.5% falls far short of 2.5-3% guidance, signalling execution and margin challenges. Management's shift to long-term 30%+ CAGR (vs prior 35-40% FY27) hints at cautious reset. Key risk: sequential deterioration suggests H2 momentum may be weaker than the bullish tone suggests.

₹177.1 Cr

Revenue · −41.2% YoY

₹2.7 Cr

Reported PAT · +5.7% YoY

Compressing

Margins · vs guidance: Mixed

Did the claims hold up?

Management's claims vs. the numbers

H1 delivered strong 78% YoY revenue growth (₹534 Cr vs ₹300 Cr)

MET

H1 FY27 ₹534 Cr standalone, H1 FY26 ₹300 Cr; Q2 FY27 ₹177.1 Cr down 41% YoY; Q1 FY27 ≈ ₹357 Cr implied

Order book looks very encouraging; 70-80% capacity utilization in H2

Partial

Q2 was lean/seasonal; management attributes Q2 weakness to seasonality not demand; H2 demand claim not yet evidenced

EBITDA margins 9-10% range maintained

MET

Q2 OPM 11.2% (within range if comparable to EBITDA); H1 EBITDA growth 60% YoY aligns with margin stability claim

NPM striving towards 3%, with improvement from lower interest costs

OVERSTATED

Q2 NPM 1.5%, well below 2.5-3% prior guidance; Q2 attributable to seasonality and interest; PAT grew only 5.7% YoY despite much higher capacity

Capacity expansions on track; EMS operational in 45 days, AC indoor 70% done by December

MET

Management confirmed timelines; no contradictory evidence in delivered result; expansion plan credible

Earnings quality

What changed since the last call

Deltas vs. the prior call

Growth guidance reset

Downgrade

Prior FY27 target 35-40% growth; now 30%+ CAGR (longer-term, less specific). Implies FY27 growth may fall short of 35%.

NPM trajectory delayed

Downgrade

Prior target 2.5-3% NPM; Q2 delivered 1.5%, deferred improvement to future quarters vs expected near-term.

Capacity expansion scope confirmed

Neutral

EMS, AC, compressor expansions proceeding on track; no scope reduction or acceleration vs prior call.

Customer additions in AC

Upgrade

Added 3 new Tier 1/2 customers in AC in addition to anchor customer; was not detailed prior.

The Q&A

Analysts pressed on compressor unit economics (unit cost ₹1,400-1,500 vs smaller players), margin trajectory, and debt refinancing. Management was direct on most points (70% utilization, 40-60% outsourcing mix maintained) but deflected on: (a) specific customer names, (b) Nasik Phase 2 revenue, (c) exact NPM improvement timeline. Overall tone was confident but slightly defensive on margin questions.

The exchanges that mattered

Outsourcing mix — Shreyansh Jain, Unknown

Answered

40-60% outsourcing mix maintained as company guideline. Industry trending towards outsourcing; we benefit by capping ourselves.

Compressor advantage — Piyush Jain, Unknown

Answered

We are only OEM/ODM supplying compressors; competing with imports on cost. Margins lower than AC/EMS now; expect improvement as backward integration (assembly) and imports reduce.

Debt management — Kunal Tokas, Unknown

Answered

Plan to refinance ₹150 Cr OCD (bridge capital) to bank debt. Target debt-equity <1. Bank borrowing at 8.25-8.4% cost.

AC capacity utilization — Kunal Tokas, Unknown

Partial

Order book ramp-up + new customer additions. Hands full now; no capacity for new customers until expanded.

Nasik Phase 2 revenue — Hemant Soni, Unknown

Dodged

Component (Sanand/Chennai) is <5% of revenue. Refrain from giving specific estimate; will grow 30-35% over 5-year block.

EMS facility utilization — Hemant Soni, Unknown

Answered

Designed for captive first, external sales to follow. 70% of added capacity for captive; expandable for external.

CapEx completion timeline — Shreya Bajaj, Unknown

Answered

No further CapEx needed for peak revenue. Current ₹80-100 Cr FY27 CapEx sufficient; most tied up or spent. Balance of work matter of execution.

Inventory management — Shreyansh Jain, Unknown

Answered

Yes, mostly. Built for seasonal RAC demand (Oct onwards); will normalize as season progresses.

Freezer demand softness — Rajas Joshi, Unknown

Partial

Demand strong; Q2 lean seasonally. Order book strong for Q3-Q4. Pass-through to brands ongoing; price stable last 6 months; pass-through slow but progressing.

AC capacity utilization — Rishabh Agrawal, Unknown

Answered

Current 1M. IDU expansion to 15 lakh capacity; 70% enhancement done, 15 lakh/1.5M/1.6M capacity peak target; Q1 FY28 with 10 lakh base.

Guidance

Forward guidance and management's confidence

FY27: 30%+ revenue CAGR (long-term), from ₹825 Cr base prior

Medium

Framed as multi-year CAGR, not FY27-specific. H1 at 78% growth suggests FY27 will exceed 30% if H2 remains strong; but Q2 weakness suggests H2 may disappoint.

EBITDA margins 9-10% range; maintain consistency

High

Q2 OPM 11.2% within range; H1 EBITDA 56 Cr with 77% growth supports margin stability claim.

NPM: striving closer to 3% (vs 2.5-3% prior); deferred improvement

Low

Q2 NPM 1.5%, well below target. Mgmt defers improvement to future quarters due to seasonality, interest costs, and working capital not yet optimized.

FY27 total CapEx ₹80-100 Cr (₹20-25 Cr product CapEx in refrigeration)

High

No further CapEx needed; current plan sufficient to reach peak capacity. Most already spent or committed.

Risks the call surfaced

Ranked by how much they should concern a holder

Execution risk

High

EMS (45 days), AC indoor (70% done, Dec target), compressor (end FY27 target), deep freezer expansion all in flight. Delays would undermine growth guidance.

Seasonality / demand risk

High

Q2 revenue -41% YoY (₹177 Cr vs ~₹301 Cr prior year). Attributed to seasonality, but magnitude steep. If H2 demand is softer than order book suggests, FY27 growth target misses.

Margin pressure

High

Q2 NPM 1.5% vs 2.5-3% guidance. Mgmt attributes to seasonality and interest; improvement deferred. If interest cost remains high or working capital doesn't improve, NPM stays depressed.

Competitive / pricing risk

Medium

Compressors are new, competing with imported Chinese units. Mgmt expects margins to improve via backward integration (assembly) and as imports reduce. But timing and magnitude uncertain.

Customer concentration

Medium

Anchor customer accounts for 40-50% of AC revenue. Loss or reduced offtake would significantly impact segment.

Management

Score 6/10. Mostly clear on numbers (H1 78% growth, EBITDA 9-10% guidance, debt ₹400 Cr). Deflected on specific customer names, Nasik Phase 2 revenue, and exact NPM timeline. Candid on challenges (Q2 lean, compressor margins, interest cost drag). H1 FY27 delivered 78% YoY growth (₹534 Cr) vs ₹300 Cr prior, hitting prior growth claims. Capacity expansions tracking schedule. But Q2 revenue miss (-41% YoY) and PAT growth only 5.7% YoY suggest execution is uneven (strong Q1, weak Q2).

What to watch next
  • 1 · Q3-Q4 FY27

    Seasonal demand upturn; order book monetization expected

  • 2 · Dec 2026

    AC indoor unit capacity expansion (targeting) + EMS facility live

  • 3 · Q4 FY27 / Q1 FY28

    Compressor capacity expansion to 6M units; backward integration in IDU/ODU begins

Key risk: sequential deterioration suggests H2 momentum may be weaker than the bullish tone suggests.

Informational and educational content only. Not investment advice.